Tech Company Financing Transactions

Blue Ash Therapeutics Funding Round

On 6/30/2010, Blue Ash Therapeutics received $2 million in financing from CincyTech and private investors.

Transaction Overview

Announced On
6/30/2010
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors

CincyTech

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 East 4th St. 1400
Cincinnati, OH 45202
USA
Email Address
Not Recorded
Overview
Blue Ash Therapeutics, LLC was formed in December 2008 in Cincinnati to bring a promising cardiovascular drug -- azimilide - to market.
Profile
Blue Ash Therapeutics LinkedIn Company Profile
Social Media
Blue Ash Therapeutics Company Twitter Account
Company News
Blue Ash Therapeutics News
Facebook
Blue Ash Therapeutics on Facebook
YouTube
Blue Ash Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Gregory Flexter
  Gregory Flexter LinkedIn Profile  Gregory Flexter Twitter Account  Gregory Flexter News  Gregory Flexter on Facebook
Chief Operating Officer
Kevin Malloy
  Kevin Malloy LinkedIn Profile  Kevin Malloy Twitter Account  Kevin Malloy News  Kevin Malloy on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2010: Dicerna Pharmaceuticals venture capital transaction
Next: 6/30/2010: Tabula Digita venture capital transaction

 

Share this article

 


News on VC Transactions

We document tech company VC transactions. VC investment data records reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary